Congenital Lipoid Adrenal Hyperplasia (STAR Deficiency): A Patient Guide
At a Glance
Congenital lipoid adrenal hyperplasia (STAR deficiency) is a lifelong genetic condition that limits cortisol, aldosterone, and sex hormone production. Children need consistent hormone replacement, illness-related stress dosing, and an emergency hydrocortisone plan.
Congenital Lipoid Adrenal Hyperplasia (LCAH), also known as STAR deficiency, is an exceptionally rare genetic condition that fundamentally changes how the body produces essential steroid hormones. In a healthy body, cholesterol serves as the “building block” for hormones that regulate everything from salt balance and blood sugar to physical development. In children with STAR deficiency, a specific protein—the StAR protein—is unable to transport this cholesterol into the part of the cell where it can be transformed into these steroids [1][2]. As a result, the body faces a shortage of cortisol, aldosterone, and sex hormones, while unused cholesterol builds up as tiny fat droplets (lipids) within the adrenal glands and gonads [3].
This condition typically follows one of two paths based on the severity of the genetic change. The classic form is the most severe and usually appears within the first few weeks or months of life, often through symptoms like persistent vomiting, poor weight gain, or a “salt-wasting” crisis where the body cannot maintain its sodium levels [4]. The non-classic form is more subtle, often appearing later in childhood with milder symptoms; these individuals may retain meaningful steroid production, though it still requires lifelong vigilance [3][5]. Because the StAR protein is also essential for making sex hormones, the condition can also influence how a child’s body develops physically before birth and during puberty, leading to unique developmental journeys that vary depending on each child’s specific genetic blueprint and variable ovarian or testicular function [2][6].
What To Do Today Checklist
- Emergency Kit: Ensure your emergency injectable hydrocortisone kit is unexpired and easily accessible.
- Action Plan: Ask your clinician to provide a signed, individualized written emergency action plan that fills in the exact oral and injectable doses for your child.
- Medical Alert: Ensure the child is wearing a medical alert bracelet.
Living with STAR deficiency is a lifelong commitment to balance, but it is a journey that many families navigate successfully. The core of daily management is replacing the hormones the body cannot make on its own through consistent, timed medications [7]. Beyond daily pills, the most critical skill for any caregiver is “stress dosing”—learning how to increase medication during times of fever or illness to prevent a medical emergency known as an adrenal crisis [6][8]. While the technical details of labs and dosing can feel overwhelming at first, the primary goal of your medical team is to ensure your child remains energetic, grows at a healthy rate, and can participate in all the typical activities of childhood [9].
Though the diagnosis is permanent, it does not define your child’s potential. With a dedicated care team—usually led by a pediatric endocrinologist—and a solid emergency plan in place, children with STAR deficiency grow, learn, and thrive [9]. As they transition through puberty and into adulthood, they will continue to work with specialists to monitor their health and explore future options for fertility and family planning [10][11]. You are not alone in this process; while the condition is rare, the medical community’s understanding of how to support these children continues to advance, focusing on a future that is bright, active, and full of possibility [12][13].
In this guide
6 chapters
Understanding Your Child's Diagnosis: STAR Deficiency
Learn what STAR deficiency (congenital lipoid adrenal hyperplasia) means, how it is inherited, and how hormone treatment supports your child's health and growth.
Biology and Subtypes: How STAR Deficiency Works
Learn how STAR deficiency causes lipoid congenital adrenal hyperplasia, including classic and non-classic forms, karyotypes, sex development, and puberty.
Symptoms and Diagnosis: Distinguishing STAR Deficiency
Learn how STAR deficiency causes lipoid congenital adrenal hyperplasia, including symptoms, cortisol and ACTH patterns, 17-OHP results, imaging, and genetic tests.
Daily Management: Balancing Your Child's Hormones
Learn daily hormone and salt management for congenital lipoid adrenal hyperplasia, including hydrocortisone dosing, growth checks, renin, electrolytes, and ACTH.
Emergency Care: Preventing and Managing Adrenal Crisis
Learn how families can prevent and respond to adrenal crisis in children with STAR deficiency, including sick-day dosing, emergency injections, and action plans.
Puberty, Fertility, and Long-Term Monitoring
Learn how congenital lipoid adrenal hyperplasia (STAR deficiency) affects puberty, fertility, gonadal health, growth, bone density, and lifelong monitoring.
Common questions in this guide
What is congenital lipoid adrenal hyperplasia caused by STAR deficiency?
How are classic and non-classic STAR deficiency different?
What is stress dosing for a child with STAR deficiency?
What should be in a STAR deficiency emergency plan?
Can children with STAR deficiency grow up and have an active life?
Get notified when new evidence is published on Congenital lipoid adrenal hyperplasia due to STAR deficency.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (13)
- 1
The Steroidogenic Acute Regulatory (STAR) Gene Anatomy, Expression, and Roles.
Lim JH, Cheon YP
Development & reproduction 2025; (29(3)):63-80 doi:10.12717/DR.2025.29.3.63.
PMID: 41103362 - 2
Disorders in the initial steps of steroid hormone synthesis.
Miller WL
The Journal of steroid biochemistry and molecular biology 2017; (165(Pt A)):18-37 doi:10.1016/j.jsbmb.2016.03.009.
PMID: 26960203 - 3
Clinical spectrum of human STAR variants and their genotype-phenotype correlation.
Altinkilic EM, Augsburger P, Pandey AV, Flück CE
The Journal of endocrinology 2024; (262(3)).
PMID: 38913505 - 4
[Clinical and StAR genetic characteristics of 33 children with congenital lipoid adrenal hyperplasia].
Zheng WQ, Duan Y, Xiao B, et al.
Zhonghua er ke za zhi = Chinese journal of pediatrics 2022; (60(10)):1066-1071 doi:10.3760/cma.j.cn112140-20220322-00233.
PMID: 36207855 - 5
Nonclassic congenital lipoid adrenal hyperplasia diagnosed at 17 months in a Korean boy with normal male genitalia: emphasis on pigmentation as a diagnostic clue.
Bae H, Kim MS, Park H, et al.
Annals of pediatric endocrinology & metabolism 2020; (25(1)):46-51 doi:10.6065/apem.2020.25.1.46.
PMID: 32252217 - 6
Adrenal Crisis in an Adult Patient With Lipoid Congenital Adrenal Hyperplasia due to STAR Protein Mutation.
Zavgorodneva Z, Kaljevic M, Chen K
AACE endocrinology and diabetes 2026; (13(5)):788-791 doi:10.1016/j.aed.2026.04.016.
PMID: 42978993 - 7
Two siblings with lipoid congenital adrenal hyperplasia: first reported case in Serbia and literature review.
Jesic MD, Kovacevic S, Zdravkovic V, et al.
Frontiers in endocrinology 2026; (17()):1912249 doi:10.3389/fendo.2026.1912249.
PMID: 42688021 - 8
Longitudinal Assessment of Illnesses, Stress Dosing, and Illness Sequelae in Patients With Congenital Adrenal Hyperplasia.
El-Maouche D, Hargreaves CJ, Sinaii N, et al.
The Journal of clinical endocrinology and metabolism 2018; (103(6)):2336-2345 doi:10.1210/jc.2018-00208.
PMID: 29584889 - 9
A case report of pedigree of a homozygous mutation of the steroidogenic acute regulatory protein causing lipoid congenital adrenal hyperplasia.
Fu R, Lu L, Jiang J, et al.
Medicine 2017; (96(21)):e6994 doi:10.1097/MD.0000000000006994.
PMID: 28538409 - 10
Clinical Characteristics and Outcomes of Korean Patients with Lipoid Congenital Adrenal Hyperplasia: An Analysis of Data from the Multicenter Networks for Ideal Outcomes of Pediatric Rare Endocrine and Metabolic Disease (OUTSPREAD) Cohort Study.
Lee Y, Kim M, Lee YJ, et al.
Endocrinology and metabolism (Seoul, Korea) 2026; (41(4)):566-578 doi:10.3803/EnM.2025.2611.
PMID: 42190700 - 11
Pubertal Development and Pregnancy Outcomes in 46,XX Patients With Nonclassic Lipoid Congenital Adrenal Hyperplasia.
Hatabu N, Amano N, Mori J, et al.
The Journal of clinical endocrinology and metabolism 2019; (104(5)):1866-1870 doi:10.1210/jc.2018-01752.
PMID: 30476142 - 12
StAR Protein Deficiency in Clinical Practice: A Case Series From Saudi Arabia.
Alabduljabbar A, Farooq D, Abid S, et al.
Case reports in endocrinology 2026; (2026()):8489134 doi:10.1155/crie/8489134.
PMID: 41502797 - 13
Frequency of stress dosing and adrenal crisis in paediatric and adult patients with congenital adrenal hyperplasia: a prospective study.
Tschaidse L, Wimmer S, Nowotny HF, et al.
European journal of endocrinology 2024; (190(4)):275-283 doi:10.1093/ejendo/lvae023.
PMID: 38584334
This page explains congenital lipoid adrenal hyperplasia and emergency planning for informational purposes only and does not constitute medical advice. Do not change your child’s medicines or emergency doses without guidance from the pediatric endocrinology team; use the individualized plan for urgent symptoms.